258 related articles for article (PubMed ID: 38016582)
1. Risks of opioid overdose among New York State Medicaid recipients with chronic pain before and during the COVID-19 pandemic.
Mannes ZL; Wheeler-Martin K; Terlizzi K; Hasin DS; Perry A; Pamplin JR; Crystal S; Cerdá M; Martins SS
Prev Med; 2023 Dec; 177():107789. PubMed ID: 38016582
[TBL] [Abstract][Full Text] [Related]
2. Association of Receipt of Opioid Use Disorder-Related Telehealth Services and Medications for Opioid Use Disorder With Fatal Drug Overdoses Among Medicare Beneficiaries Before and During the COVID-19 Pandemic.
Jones CM; Shoff C; Blanco C; Losby JL; Ling SM; Compton WM
JAMA Psychiatry; 2023 May; 80(5):508-514. PubMed ID: 36988913
[TBL] [Abstract][Full Text] [Related]
3. Receipt of Telehealth Services, Receipt and Retention of Medications for Opioid Use Disorder, and Medically Treated Overdose Among Medicare Beneficiaries Before and During the COVID-19 Pandemic.
Jones CM; Shoff C; Hodges K; Blanco C; Losby JL; Ling SM; Compton WM
JAMA Psychiatry; 2022 Oct; 79(10):981-992. PubMed ID: 36044198
[TBL] [Abstract][Full Text] [Related]
4. Discontinuation and tapering of prescribed opioids and risk of overdose among people on long-term opioid therapy for pain with and without opioid use disorder in British Columbia, Canada: A retrospective cohort study.
Kennedy MC; Crabtree A; Nolan S; Mok WY; Cui Z; Chong M; Slaunwhite A; Ti L
PLoS Med; 2022 Dec; 19(12):e1004123. PubMed ID: 36454732
[TBL] [Abstract][Full Text] [Related]
5. State- and County-Level Geographic Variation in Opioid Use Disorder, Medication Treatment, and Opioid-Related Overdose Among Medicaid Enrollees.
Lindner SR; Hart K; Manibusan B; McCarty D; McConnell KJ
JAMA Health Forum; 2023 Jun; 4(6):e231574. PubMed ID: 37351873
[TBL] [Abstract][Full Text] [Related]
6. Independent and joint contributions of physical disability and chronic pain to incident opioid use disorder and opioid overdose among Medicaid patients.
Hoffman KL; Milazzo F; Williams NT; Samples H; Olfson M; Diaz I; Doan L; Cerda M; Crystal S; Rudolph KE
Psychol Med; 2024 May; 54(7):1419-1430. PubMed ID: 37974483
[TBL] [Abstract][Full Text] [Related]
7. Predictors of enrollment in opioid agonist therapy after opioid overdose or diagnosis with opioid use disorder: A cohort study.
Macmadu A; Paull K; Youssef R; Batthala S; Wilson KH; Samuels EA; Yedinak JL; Marshall BDL
Drug Alcohol Depend; 2021 Feb; 219():108435. PubMed ID: 33310383
[TBL] [Abstract][Full Text] [Related]
8. Association between treatment setting and outcomes among oregon medicaid patients with opioid use disorder: a retrospective cohort study.
Hartung DM; Markwardt S; Johnston K; Geddes J; Baker R; Leichtling G; Hildebran C; Chan B; Cook RR; McCarty D; Ghitza U; Korthuis PT
Addict Sci Clin Pract; 2022 Aug; 17(1):45. PubMed ID: 35986384
[TBL] [Abstract][Full Text] [Related]
9. The impact of the implementation of medication for opioid use disorder and COVID-19 in a statewide correctional system on treatment engagement, postrelease continuation of care, and overdose.
Klemperer EM; Wreschnig L; Crocker A; King-Mohr J; Ramniceanu A; Brooklyn JR; Peck KR; Rawson RA; Evans EA
J Subst Use Addict Treat; 2023 Sep; 152():209103. PubMed ID: 37311520
[TBL] [Abstract][Full Text] [Related]
10. Trends in opioid use disorder and overdose among opioid-naive individuals receiving an opioid prescription in Massachusetts from 2011 to 2014.
Burke LG; Zhou X; Boyle KL; Orav EJ; Bernson D; Hood ME; Land T; Bharel M; Frakt AB
Addiction; 2020 Mar; 115(3):493-504. PubMed ID: 31691390
[TBL] [Abstract][Full Text] [Related]
11. Healthcare costs and use before and after opioid overdose in Veterans Health Administration patients with opioid use disorder.
Joyce VR; Oliva EM; Garcia CC; Trafton J; Asch SM; Wagner TH; Humphreys K; Owens DK; Bounthavong M
Addiction; 2023 Nov; 118(11):2203-2214. PubMed ID: 37465971
[TBL] [Abstract][Full Text] [Related]
12. Telemedicine Buprenorphine Initiation and Retention in Opioid Use Disorder Treatment for Medicaid Enrollees.
Hammerslag LR; Mack A; Chandler RK; Fanucchi LC; Feaster DJ; LaRochelle MR; Lofwall MR; Nau M; Villani J; Walsh SL; Westgate PM; Slavova S; Talbert JC
JAMA Netw Open; 2023 Oct; 6(10):e2336914. PubMed ID: 37851446
[TBL] [Abstract][Full Text] [Related]
13. Utilization and disparities in medication treatment for opioid use disorder among patients with comorbid opioid use disorder and chronic pain during the COVID-19 pandemic.
Perry A; Wheeler-Martin K; Hasin DS; Terlizzi K; Mannes ZL; Jent V; Townsend TN; Pamplin JR; Crystal S; Martins SS; Cerdá M; Krawczyk N
Drug Alcohol Depend; 2023 Dec; 253():111023. PubMed ID: 37984034
[TBL] [Abstract][Full Text] [Related]
14. Dynamic changes in methadone utilisation for opioid use disorder treatment: a retrospective observational study during the COVID-19 pandemic.
Kennalley AL; Fanelli JL; Furst JA; Mynarski NJ; Jarvis MA; Nichols SD; McCall KL; Piper BJ
BMJ Open; 2023 Nov; 13(11):e074845. PubMed ID: 37973543
[TBL] [Abstract][Full Text] [Related]
15. Systematic Evaluation of State Policy Interventions Targeting the US Opioid Epidemic, 2007-2018.
Lee B; Zhao W; Yang KC; Ahn YY; Perry BL
JAMA Netw Open; 2021 Feb; 4(2):e2036687. PubMed ID: 33576816
[TBL] [Abstract][Full Text] [Related]
16. Associations Between the Specialty of Opioid Prescribers and Opioid Addiction, Misuse, and Overdose Outcomes.
Lobo CP; Cochran G; Chang CH; Gellad WF; Gordon AJ; Jalal H; Lo-Ciganic WH; Karp JF; Kelley D; Donohue JM
Pain Med; 2020 Sep; 21(9):1871-1890. PubMed ID: 31626295
[TBL] [Abstract][Full Text] [Related]
17. Maternal and infant characteristics associated with maternal opioid overdose in the year following delivery.
Nielsen T; Bernson D; Terplan M; Wakeman SE; Yule AM; Mehta PK; Bharel M; Diop H; Taveras EM; Wilens TE; Schiff DM
Addiction; 2020 Feb; 115(2):291-301. PubMed ID: 31692133
[TBL] [Abstract][Full Text] [Related]
18. The association between community social vulnerability and prescription opioid availability with individual opioid overdose.
El Ibrahimi S; Hendricks MA; Little K; Ritter GA; Flores D; Loy B; Wright D; Weiner SG
Drug Alcohol Depend; 2023 Nov; 252():110991. PubMed ID: 37862877
[TBL] [Abstract][Full Text] [Related]
19. Examining buprenorphine diversion through a harm reduction lens: an agent-based modeling study.
Adams JW; Duprey M; Khan S; Cance J; Rice DP; Bobashev G
Harm Reduct J; 2023 Oct; 20(1):150. PubMed ID: 37848945
[TBL] [Abstract][Full Text] [Related]
20. Trends in prescription opioid use and dose trajectories before opioid use disorder or overdose in US adults from 2006 to 2016: A cross-sectional study.
Wei YJ; Chen C; Fillingim R; Schmidt SO; Winterstein AG
PLoS Med; 2019 Nov; 16(11):e1002941. PubMed ID: 31689302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
